Rock Springs Capital Management LP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$14,715,000
+14.2%
4,921,487
+1.3%
0.37%
+24.2%
Q4 2021$12,880,000
-26.0%
4,860,200
+1.4%
0.30%
-18.6%
Q3 2021$17,400,000
-15.7%
4,793,400
+0.8%
0.37%
-10.3%
Q2 2021$20,636,000
+27.2%
4,754,900
+0.3%
0.41%
+15.3%
Q1 2021$16,218,000
-2.3%
4,742,000
-0.0%
0.35%
+0.6%
Q4 2020$16,600,000
+45.8%
4,742,8910.0%0.35%
+21.8%
Q3 2020$11,383,000
+5.5%
4,742,891
-19.6%
0.29%
-2.4%
Q2 2020$10,793,000
+25.8%
5,897,642
+7.2%
0.30%
-16.6%
Q1 2020$8,580,000
-27.1%
5,500,000
+0.0%
0.36%
-4.6%
Q4 2019$11,766,000
+49.8%
5,497,900
+30.9%
0.37%
+18.8%
Q3 2019$7,854,000
-28.4%
4,200,0000.0%0.31%
-21.2%
Q2 2019$10,962,000
+1.6%
4,200,0000.0%0.40%
-4.6%
Q1 2019$10,794,000
+11.7%
4,200,0000.0%0.42%
-8.8%
Q4 2018$9,660,000
-27.0%
4,200,000
+1.8%
0.46%
-4.8%
Q3 2018$13,241,000
+18.4%
4,125,000
+4.4%
0.48%
+11.4%
Q2 2018$11,179,000
+22.6%
3,950,000
+53.4%
0.43%
+10.5%
Q1 2018$9,116,000
-5.1%
2,575,000
+4.0%
0.39%
-10.8%
Q4 2017$9,603,000
+278.1%
2,475,000
+147.5%
0.44%
+272.6%
Q3 2017$2,540,000
-7.0%
1,000,0000.0%0.12%
-15.2%
Q2 2017$2,730,000
-17.5%
1,000,0000.0%0.14%
-27.7%
Q1 2017$3,310,000
+39.1%
1,000,0000.0%0.19%
+20.1%
Q4 2016$2,380,000
-64.2%
1,000,000
-44.8%
0.16%
-61.8%
Q3 2016$6,643,000
+70.2%
1,810,000
+3.4%
0.42%
+43.9%
Q2 2016$3,903,000
+28.2%
1,750,000
+19.5%
0.29%
+13.3%
Q1 2016$3,045,000
-8.6%
1,464,050
+33.1%
0.26%
+0.8%
Q4 2015$3,333,0001,100,0000.25%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders